Michael K. McGarrity
Director Ejecutivo en MDXHEALTH SA .
Fortuna: - $ al 30/04/2024
Perfil
Michael K.
McGarrity is currently the Chief Executive Officer & Executive Director at MDxHealth SA, the Chief Executive Officer & Director at MDxHealth, Inc., and the Chairman at LeviSense Medical, Inc. Previously, he served as the President, Chief Executive Officer & Director at Nanosphere, Inc. from 2013 to 2016, the Chief Executive Officer at Sterilis Solutions, LLC from 2017 to 2018, and the Vice President-Marketing at Stryker Corp.
from 1993 to 2005.
He obtained his undergraduate degree from the University of Notre Dame.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
MDXHEALTH S.A.
-.--% | 31/03/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Cargos activos de Michael K. McGarrity
Empresas | Cargo | Inicio |
---|---|---|
MDXHEALTH SA | Director Ejecutivo | 18/02/2019 |
LeviSense Medical, Inc. | Presidente | - |
MDxHealth, Inc.
MDxHealth, Inc. BiotechnologyHealth Technology Part of MDxHealth SA, MDxHealth, Inc. is a precision diagnostics company that specializes in providing personalized molecular diagnostic information for the diagnosis and treatment of cancer. The company is based in Irvine, CA, with laboratory operations in Nijmegen and headquarters in Herstal, Belgium. The company's tests are based on proprietary genetic and epigenetic technologies that assist physicians in diagnosing urologic cancers and predicting recurrence risk. MDxHealth's ConfirmMDx for Prostate Cancer test helps to rule-in high-risk men who have had a previous negative biopsy result and rule-out otherwise cancer-free men from undergoing unnecessary repeat biopsies and screening procedures. | Director Ejecutivo | - |
Antiguos cargos conocidos de Michael K. McGarrity.
Empresas | Cargo | Fin |
---|---|---|
Sterilis Solutions, LLC
Sterilis Solutions, LLC Medical SpecialtiesHealth Technology Sterilis LLC develops regulated medical waste remediation device. It sterilizes and grinds medical waste, rendering it acceptable for disposal in regular trash as described in OSHA and State regulations. The company was founded by Jeffrey H. Bell in June 2011 and is headquartered in Boxborough, MA. | Director Ejecutivo | 01/01/2018 |
NANOSPHERE, INC. | Director Ejecutivo | 01/09/2016 |
STRYKER CORPORATION | Ventas & Marketing | 01/01/2005 |
Formación de Michael K. McGarrity.
University of Notre Dame | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
STRYKER CORPORATION | Health Technology |
MDXHEALTH SA | Health Technology |
Empresas privadas | 4 |
---|---|
Nanosphere, Inc.
Nanosphere, Inc. Medical SpecialtiesHealth Technology Nanosphere, Inc. engages in the development, manufacture, and market of molecular diagnostics platform. Its platform, Verigene System, enables clinicians to identify and treat bacteria and viruses responsible for some of the most complex, costly, and deadly infectious diseases. The company was founded by Chad A. Mirkin and Robert Letsinger on December 30, 1999 and is headquartered in Northbrook, IL. | Health Technology |
Sterilis Solutions, LLC
Sterilis Solutions, LLC Medical SpecialtiesHealth Technology Sterilis LLC develops regulated medical waste remediation device. It sterilizes and grinds medical waste, rendering it acceptable for disposal in regular trash as described in OSHA and State regulations. The company was founded by Jeffrey H. Bell in June 2011 and is headquartered in Boxborough, MA. | Health Technology |
LeviSense Medical, Inc. | |
MDxHealth, Inc.
MDxHealth, Inc. BiotechnologyHealth Technology Part of MDxHealth SA, MDxHealth, Inc. is a precision diagnostics company that specializes in providing personalized molecular diagnostic information for the diagnosis and treatment of cancer. The company is based in Irvine, CA, with laboratory operations in Nijmegen and headquarters in Herstal, Belgium. The company's tests are based on proprietary genetic and epigenetic technologies that assist physicians in diagnosing urologic cancers and predicting recurrence risk. MDxHealth's ConfirmMDx for Prostate Cancer test helps to rule-in high-risk men who have had a previous negative biopsy result and rule-out otherwise cancer-free men from undergoing unnecessary repeat biopsies and screening procedures. | Health Technology |
- Bolsa de valores
- Insiders
- Michael K. McGarrity